BioCentury
ARTICLE | Top Story

Juno raises $134 million in B round

August 6, 2014 12:59 AM UTC

Cancer immunotherapy company Juno Therapeutics Inc. (Seattle, Wash.) raised $134 million in a series B round from 10 undisclosed, new public mutual funds and healthcare-focused funds. The company said all of its "major" existing investors also participated in the round, but declined to provide details. Including the B round, Juno has now raised $310 million in just a few months. The company raised $176 million in a tranched series A round that closed earlier this year (see BioCentury Extra, April 24). ...